grade and used as received unless indicated otherwise. The purity
of all tested compounds is >95% on the basis of liquid chromatography–mass
spectrometry (LC-MS) and nuclear magnetic resonance (NMR). 1H- and 13C NMR spectra were recorded on a Bruker AV-400
(400 MHz), AV-600 (600 MHz), or AV-850 (850 MHz) spectrometer. Chemical
shifts are given in ppm (δ) relative to CD3OD or
CDCl3 as an internal standard. Coupling constants are given
in Hz, and peak assignments are based on 2D 1H correlation
spectroscopy and 13C heteronuclear single quantum coherence
NMR experiments. All 13C attached proton test spectra are
proton-decoupled. LC-MS analysis was performed on a Finnigan Surveyor
high-performance liquid chromatography (HPLC) system with a Gemini
C18 50 × 4.60 mm column (detection at 200–600 nm) coupled
to a Finnigan LCQ Advantage Max mass spectrometer with electrospray
ionization (ESI). Methods used are: 15 min (0–0.5 min: 10%
MeCN; 0.5–10.5 min: 10–90% MeCN; 10.5–12.5 min:
90% MeCN; 12.5–15 min: 90–10% MeCN) or 12.5 min (0–0.5
min: 10% MeCN; 0.5–8.5 min: 10–90% MeCN; 8.5–10.5
min: 90% MeCN; 10.5–12.5 min: 90––10% MeCN).
HRMS was recorded on an LTQ Orbitrap (ThermoFinnigan). For reverse-phase
HPLC purification, an automated Gilson HPLC system equipped with a
C18 semiprep column (Phenomenex Gemini C18, 5 μm 250 ×
10 mm) and a GX281 fraction collector was used.